Filing Details
- Accession Number:
- 0001127602-12-033825
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-13 16:18:26
- Reporting Period:
- 2012-12-11
- Filing Date:
- 2012-12-13
- Accepted Time:
- 2012-12-13 16:18:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216055 | N Marc Casper | 81 Wyman Street Waltham MA 02451 | Chief Executive Officer | Yes | Yes | No | No |
Transaction Summary
| Sold: | 126,900 shares | Avg. Price: $65.00 | Total Value: $8,248,500.00 |
| Number of Shares After Transactions: | 423,785 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-11 | 126,900 | $43.37 | 552,235 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-11 | 126,900 | $65.00 | 425,335 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-11 | 1,550 | $0.00 | 423,785 | No | 5 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-12-11 | 126,900 | $0.00 | 126,900 | $43.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-11-09 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2012.
- The option vested in five equal annual installments on November 9, 2007, 2008, 2009, 2010, and 2011.
Billionaire Hedge Funds
